About
Technology
Issues
FAQ
Links
Official Page
Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.